Patel, G.; Iskandar, B.; Chelikam, N.; Jain, S.; Vyas, V.; Singla, T.; Dondapati, L.; Bombaywala, A.; Peela, A.S.; Khealani, M.;
et al. Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis. Hearts 2023, 4, 61-72.
https://doi.org/10.3390/hearts4030008
AMA Style
Patel G, Iskandar B, Chelikam N, Jain S, Vyas V, Singla T, Dondapati L, Bombaywala A, Peela AS, Khealani M,
et al. Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis. Hearts. 2023; 4(3):61-72.
https://doi.org/10.3390/hearts4030008
Chicago/Turabian Style
Patel, Ghanshyam, Beshoy Iskandar, Nikhila Chelikam, Siddhant Jain, Vandit Vyas, Tanvi Singla, Lavanya Dondapati, Ali Bombaywala, Appala Suman Peela, Milan Khealani,
and et al. 2023. "Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis" Hearts 4, no. 3: 61-72.
https://doi.org/10.3390/hearts4030008
APA Style
Patel, G., Iskandar, B., Chelikam, N., Jain, S., Vyas, V., Singla, T., Dondapati, L., Bombaywala, A., Peela, A. S., Khealani, M., Mukesh, S., Korsapati, H. R., Korsapati, A. R., Regassa, H., Jain, N., Patel, U., & Venkata, V. S.
(2023). Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis. Hearts, 4(3), 61-72.
https://doi.org/10.3390/hearts4030008
